| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Extremely Premature | 39 | 2025 | 112 | 5.400 |
Why?
|
| Swine | 96 | 2025 | 1191 | 2.970 |
Why?
|
| Enterocolitis, Necrotizing | 28 | 2025 | 255 | 2.920 |
Why?
|
| Neonatal Sepsis | 11 | 2025 | 40 | 2.870 |
Why?
|
| Intestinal Mucosa | 44 | 2025 | 765 | 2.800 |
Why?
|
| Stillbirth | 19 | 2022 | 103 | 2.780 |
Why?
|
| Animals, Newborn | 62 | 2025 | 1023 | 2.610 |
Why?
|
| Infant, Premature, Diseases | 19 | 2025 | 255 | 2.520 |
Why?
|
| Enteral Nutrition | 31 | 2025 | 281 | 2.420 |
Why?
|
| Infant, Newborn | 106 | 2025 | 8604 | 1.870 |
Why?
|
| Infant, Premature | 32 | 2024 | 858 | 1.800 |
Why?
|
| Parenteral Nutrition | 19 | 2025 | 216 | 1.710 |
Why?
|
| Sepsis | 10 | 2025 | 501 | 1.550 |
Why?
|
| Citrulline | 10 | 2025 | 120 | 1.470 |
Why?
|
| Protein Biosynthesis | 21 | 2022 | 580 | 1.450 |
Why?
|
| Premature Birth | 19 | 2022 | 414 | 1.440 |
Why?
|
| Intestines | 26 | 2025 | 592 | 1.250 |
Why?
|
| Gestational Age | 36 | 2025 | 1235 | 1.190 |
Why?
|
| Glucagon-Like Peptide 2 | 20 | 2019 | 55 | 1.180 |
Why?
|
| Intestine, Small | 12 | 2019 | 287 | 1.130 |
Why?
|
| Parenteral Nutrition, Total | 19 | 2014 | 114 | 1.120 |
Why?
|
| Liver | 25 | 2025 | 1802 | 1.100 |
Why?
|
| Leadership | 2 | 2021 | 244 | 1.080 |
Why?
|
| Amino Acids | 19 | 2023 | 620 | 1.080 |
Why?
|
| Escherichia coli Infections | 3 | 2020 | 195 | 0.980 |
Why?
|
| Glutamic Acid | 12 | 2013 | 209 | 0.970 |
Why?
|
| Short Bowel Syndrome | 7 | 2020 | 63 | 0.950 |
Why?
|
| Arginine | 9 | 2025 | 344 | 0.920 |
Why?
|
| Neurodevelopmental Disorders | 12 | 2025 | 621 | 0.900 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2020 | 339 | 0.870 |
Why?
|
| Fat Emulsions, Intravenous | 7 | 2025 | 80 | 0.860 |
Why?
|
| Intestinal Absorption | 18 | 2017 | 170 | 0.860 |
Why?
|
| Streptococcal Infections | 3 | 2022 | 248 | 0.850 |
Why?
|
| Animals | 125 | 2025 | 34460 | 0.840 |
Why?
|
| Female | 135 | 2025 | 71316 | 0.810 |
Why?
|
| Pregnancy | 50 | 2025 | 7577 | 0.800 |
Why?
|
| Infant, Newborn, Diseases | 6 | 2023 | 181 | 0.800 |
Why?
|
| Cholestasis | 6 | 2025 | 165 | 0.780 |
Why?
|
| Bile Acids and Salts | 9 | 2025 | 259 | 0.750 |
Why?
|
| Adaptation, Physiological | 9 | 2019 | 261 | 0.740 |
Why?
|
| Escherichia coli | 2 | 2020 | 984 | 0.740 |
Why?
|
| Humans | 154 | 2025 | 131967 | 0.730 |
Why?
|
| Intestinal Perforation | 5 | 2024 | 50 | 0.720 |
Why?
|
| United States | 37 | 2025 | 11827 | 0.710 |
Why?
|
| Gentamicins | 2 | 2022 | 87 | 0.710 |
Why?
|
| Birth Weight | 7 | 2024 | 346 | 0.690 |
Why?
|
| Animal Nutritional Physiological Phenomena | 8 | 2021 | 63 | 0.690 |
Why?
|
| Licensure, Medical | 1 | 2020 | 22 | 0.630 |
Why?
|
| Medicine | 1 | 2021 | 102 | 0.630 |
Why?
|
| Infant, Extremely Low Birth Weight | 10 | 2021 | 41 | 0.610 |
Why?
|
| Gastrointestinal Tract | 7 | 2018 | 225 | 0.600 |
Why?
|
| Peptides | 10 | 2014 | 834 | 0.600 |
Why?
|
| Glutamine | 14 | 2018 | 202 | 0.580 |
Why?
|
| Developmental Disabilities | 9 | 2021 | 771 | 0.580 |
Why?
|
| Physicians, Women | 1 | 2019 | 50 | 0.570 |
Why?
|
| Pediatricians | 1 | 2019 | 74 | 0.560 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2025 | 500 | 0.560 |
Why?
|
| Bronchopulmonary Dysplasia | 7 | 2022 | 214 | 0.550 |
Why?
|
| Intracranial Hemorrhages | 6 | 2022 | 79 | 0.550 |
Why?
|
| Jejunum | 7 | 2020 | 124 | 0.550 |
Why?
|
| Fluid Therapy | 2 | 2018 | 145 | 0.540 |
Why?
|
| Prospective Studies | 27 | 2025 | 6522 | 0.530 |
Why?
|
| Infant | 33 | 2025 | 13332 | 0.530 |
Why?
|
| Leukomalacia, Periventricular | 5 | 2018 | 15 | 0.520 |
Why?
|
| Infant Nutritional Physiological Phenomena | 6 | 2020 | 172 | 0.520 |
Why?
|
| Soybean Oil | 9 | 2025 | 71 | 0.520 |
Why?
|
| Disease Models, Animal | 17 | 2025 | 4684 | 0.510 |
Why?
|
| Indomethacin | 5 | 2017 | 81 | 0.500 |
Why?
|
| Models, Animal | 7 | 2021 | 460 | 0.500 |
Why?
|
| Receptors, Glucagon | 3 | 2014 | 32 | 0.500 |
Why?
|
| Ileum | 6 | 2020 | 124 | 0.490 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2017 | 302 | 0.490 |
Why?
|
| Diarrhea | 1 | 2018 | 312 | 0.490 |
Why?
|
| Male | 85 | 2025 | 65357 | 0.470 |
Why?
|
| Amino Acids, Sulfur | 4 | 2009 | 15 | 0.470 |
Why?
|
| Sus scrofa | 10 | 2020 | 115 | 0.450 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 5 | 2019 | 78 | 0.450 |
Why?
|
| Case-Control Studies | 17 | 2022 | 3453 | 0.440 |
Why?
|
| Fish Oils | 7 | 2021 | 82 | 0.440 |
Why?
|
| Streptococcus agalactiae | 3 | 2022 | 102 | 0.430 |
Why?
|
| Fetal Death | 6 | 2016 | 120 | 0.430 |
Why?
|
| Milk, Human | 5 | 2025 | 318 | 0.420 |
Why?
|
| Digestive System | 3 | 2003 | 61 | 0.420 |
Why?
|
| Meningitis, Bacterial | 1 | 2015 | 98 | 0.420 |
Why?
|
| Fatty Liver | 3 | 2012 | 218 | 0.420 |
Why?
|
| Cerebral Hemorrhage | 5 | 2020 | 157 | 0.420 |
Why?
|
| Dietary Supplements | 6 | 2025 | 454 | 0.420 |
Why?
|
| Cohort Studies | 15 | 2025 | 5122 | 0.410 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 63 | 0.410 |
Why?
|
| Risk Factors | 25 | 2022 | 10998 | 0.410 |
Why?
|
| Dietary Proteins | 9 | 2011 | 217 | 0.400 |
Why?
|
| Syphilis, Congenital | 4 | 2019 | 32 | 0.400 |
Why?
|
| Placenta | 5 | 2022 | 527 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1307 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2025 | 329 | 0.390 |
Why?
|
| Child Welfare | 1 | 2013 | 68 | 0.380 |
Why?
|
| Muscle, Skeletal | 6 | 2023 | 1004 | 0.380 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 31 | 0.380 |
Why?
|
| Ornithine | 1 | 2012 | 32 | 0.380 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2018 | 232 | 0.370 |
Why?
|
| Leucine | 9 | 2023 | 263 | 0.370 |
Why?
|
| Diet | 9 | 2018 | 1118 | 0.370 |
Why?
|
| Adult | 37 | 2025 | 31734 | 0.370 |
Why?
|
| Liver Diseases | 5 | 2020 | 383 | 0.370 |
Why?
|
| Pregnancy Complications | 6 | 2020 | 547 | 0.370 |
Why?
|
| Logistic Models | 12 | 2022 | 1838 | 0.370 |
Why?
|
| Animal Feed | 6 | 2018 | 76 | 0.370 |
Why?
|
| Live Birth | 7 | 2022 | 69 | 0.370 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 398 | 0.360 |
Why?
|
| Amino Acids, Essential | 3 | 2018 | 22 | 0.360 |
Why?
|
| Pediatrics | 3 | 2016 | 1239 | 0.360 |
Why?
|
| Organ Size | 10 | 2016 | 437 | 0.360 |
Why?
|
| Cesarean Section | 8 | 2021 | 436 | 0.350 |
Why?
|
| Infant Mortality | 9 | 2023 | 184 | 0.350 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2018 | 145 | 0.340 |
Why?
|
| Research | 1 | 2013 | 269 | 0.340 |
Why?
|
| Polyethylene Glycols | 2 | 2024 | 245 | 0.340 |
Why?
|
| Physicians | 1 | 2018 | 634 | 0.340 |
Why?
|
| Fatty Acids | 4 | 2021 | 377 | 0.340 |
Why?
|
| Incidence | 8 | 2025 | 3352 | 0.340 |
Why?
|
| Phytosterols | 3 | 2021 | 28 | 0.330 |
Why?
|
| Hydrocortisone | 3 | 2022 | 224 | 0.330 |
Why?
|
| Young Adult | 16 | 2022 | 10108 | 0.330 |
Why?
|
| Insulin | 7 | 2024 | 1154 | 0.330 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 140 | 0.330 |
Why?
|
| Hepatitis | 1 | 2010 | 57 | 0.320 |
Why?
|
| Glucose | 12 | 2024 | 850 | 0.320 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2025 | 259 | 0.320 |
Why?
|
| Portal Vein | 6 | 2007 | 88 | 0.310 |
Why?
|
| Parturition | 2 | 2022 | 67 | 0.310 |
Why?
|
| Intensive Care Units, Neonatal | 5 | 2025 | 343 | 0.310 |
Why?
|
| Phenylalanine | 3 | 1999 | 126 | 0.310 |
Why?
|
| Isotope Labeling | 3 | 2017 | 93 | 0.300 |
Why?
|
| Insulin Resistance | 2 | 2012 | 683 | 0.300 |
Why?
|
| Gastric Mucosa | 3 | 2009 | 492 | 0.290 |
Why?
|
| Ketoglutaric Acids | 5 | 2006 | 23 | 0.290 |
Why?
|
| Lactase | 5 | 2009 | 42 | 0.290 |
Why?
|
| Methionine | 5 | 2011 | 97 | 0.290 |
Why?
|
| Phospholipids | 3 | 2019 | 103 | 0.290 |
Why?
|
| Pregnancy in Diabetics | 2 | 2020 | 15 | 0.290 |
Why?
|
| Life Support Care | 2 | 2020 | 51 | 0.290 |
Why?
|
| Vitamin E | 3 | 2019 | 63 | 0.290 |
Why?
|
| Withholding Treatment | 2 | 2020 | 76 | 0.290 |
Why?
|
| Glucagon-Like Peptides | 12 | 2011 | 40 | 0.290 |
Why?
|
| Fetal Development | 3 | 2018 | 128 | 0.280 |
Why?
|
| Oxidation-Reduction | 11 | 2012 | 442 | 0.270 |
Why?
|
| Nutritional Physiological Phenomena | 6 | 2019 | 85 | 0.270 |
Why?
|
| Inflammation | 7 | 2024 | 1500 | 0.270 |
Why?
|
| Meningitis | 2 | 2021 | 98 | 0.270 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 67 | 0.270 |
Why?
|
| Child Development | 2 | 2023 | 274 | 0.270 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2020 | 76 | 0.270 |
Why?
|
| Lysine | 3 | 2003 | 175 | 0.260 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2022 | 853 | 0.260 |
Why?
|
| Neonatal Screening | 3 | 2018 | 195 | 0.260 |
Why?
|
| Resuscitation | 3 | 2019 | 280 | 0.260 |
Why?
|
| Postprandial Period | 2 | 2004 | 86 | 0.260 |
Why?
|
| Fibroblast Growth Factors | 4 | 2022 | 169 | 0.260 |
Why?
|
| Laparotomy | 3 | 2024 | 144 | 0.260 |
Why?
|
| Delivery, Obstetric | 2 | 2022 | 259 | 0.260 |
Why?
|
| Colostrum | 3 | 2017 | 58 | 0.260 |
Why?
|
| Splanchnic Circulation | 4 | 2011 | 49 | 0.260 |
Why?
|
| Gastrointestinal Diseases | 2 | 2009 | 340 | 0.250 |
Why?
|
| Infant Formula | 5 | 2025 | 104 | 0.250 |
Why?
|
| Swine Diseases | 3 | 2020 | 40 | 0.250 |
Why?
|
| Emulsions | 6 | 2025 | 70 | 0.250 |
Why?
|
| Growth | 3 | 2014 | 92 | 0.250 |
Why?
|
| Weight Gain | 7 | 2019 | 384 | 0.240 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2022 | 60 | 0.240 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2018 | 63 | 0.240 |
Why?
|
| Retrospective Studies | 24 | 2025 | 17703 | 0.240 |
Why?
|
| Patient Discharge | 3 | 2019 | 512 | 0.240 |
Why?
|
| Blood Glucose | 3 | 2019 | 1104 | 0.240 |
Why?
|
| Hospital Mortality | 6 | 2022 | 1076 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2016 | 1626 | 0.240 |
Why?
|
| History, 20th Century | 2 | 2018 | 366 | 0.240 |
Why?
|
| Nitrogen | 2 | 2012 | 122 | 0.240 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2014 | 170 | 0.240 |
Why?
|
| Respiration, Artificial | 3 | 2018 | 501 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 6 | 2022 | 2578 | 0.230 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 372 | 0.230 |
Why?
|
| Lipopolysaccharides | 3 | 2024 | 302 | 0.230 |
Why?
|
| Candida | 2 | 2018 | 79 | 0.220 |
Why?
|
| Hydrocephalus | 2 | 2018 | 292 | 0.220 |
Why?
|
| Hydrolases | 2 | 2024 | 61 | 0.220 |
Why?
|
| Ampicillin | 2 | 2022 | 59 | 0.210 |
Why?
|
| Syphilis | 3 | 2019 | 94 | 0.210 |
Why?
|
| Lactose | 3 | 2018 | 53 | 0.210 |
Why?
|
| Food, Formulated | 4 | 2012 | 38 | 0.210 |
Why?
|
| Endotoxemia | 1 | 2024 | 54 | 0.210 |
Why?
|
| Drainage | 2 | 2024 | 253 | 0.210 |
Why?
|
| Homeostasis | 2 | 2021 | 714 | 0.200 |
Why?
|
| C-Reactive Protein | 2 | 2024 | 459 | 0.200 |
Why?
|
| Threonine | 4 | 2012 | 62 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2021 | 4693 | 0.200 |
Why?
|
| Brain | 6 | 2019 | 3247 | 0.200 |
Why?
|
| beta Carotene | 1 | 2023 | 37 | 0.200 |
Why?
|
| Child, Preschool | 9 | 2025 | 15066 | 0.200 |
Why?
|
| Biomarkers | 6 | 2024 | 3415 | 0.200 |
Why?
|
| Body Weight | 6 | 2018 | 990 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 838 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2018 | 90 | 0.190 |
Why?
|
| Carbon Isotopes | 7 | 2017 | 230 | 0.190 |
Why?
|
| Prenatal Care | 6 | 2020 | 346 | 0.190 |
Why?
|
| Placental Insufficiency | 1 | 2022 | 14 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2015 | 157 | 0.190 |
Why?
|
| Motor Skills | 2 | 2020 | 75 | 0.190 |
Why?
|
| Biological Availability | 5 | 2021 | 140 | 0.190 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 159 | 0.180 |
Why?
|
| Child | 11 | 2024 | 26332 | 0.180 |
Why?
|
| Probiotics | 2 | 2023 | 231 | 0.180 |
Why?
|
| Bacteria | 2 | 2022 | 541 | 0.180 |
Why?
|
| Fructosamine | 1 | 2021 | 11 | 0.180 |
Why?
|
| Kinetics | 10 | 2021 | 1105 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2025 | 220 | 0.180 |
Why?
|
| Homocysteine | 4 | 2011 | 118 | 0.180 |
Why?
|
| Digestive System Physiological Phenomena | 2 | 2000 | 9 | 0.180 |
Why?
|
| Anti-Infective Agents | 2 | 2022 | 265 | 0.180 |
Why?
|
| Fungemia | 1 | 2021 | 22 | 0.180 |
Why?
|
| Viscera | 3 | 2006 | 55 | 0.170 |
Why?
|
| Cysteine | 4 | 2011 | 140 | 0.170 |
Why?
|
| Triglycerides | 4 | 2019 | 605 | 0.170 |
Why?
|
| Proteins | 7 | 2006 | 1028 | 0.170 |
Why?
|
| Random Allocation | 6 | 2018 | 423 | 0.170 |
Why?
|
| Muscle Proteins | 3 | 2022 | 404 | 0.170 |
Why?
|
| Nitric Oxide | 3 | 2018 | 467 | 0.170 |
Why?
|
| Duodenum | 2 | 2020 | 112 | 0.170 |
Why?
|
| Oxylipins | 1 | 2021 | 6 | 0.170 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 14 | 0.170 |
Why?
|
| Gastric Emptying | 2 | 2013 | 78 | 0.170 |
Why?
|
| Sodium Glutamate | 2 | 2013 | 6 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 328 | 0.170 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2022 | 111 | 0.170 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 88 | 0.170 |
Why?
|
| Eating | 3 | 2019 | 382 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2023 | 172 | 0.160 |
Why?
|
| Kidney | 5 | 2019 | 1304 | 0.160 |
Why?
|
| Infant Behavior | 1 | 2020 | 16 | 0.160 |
Why?
|
| Cerebral Ventricles | 1 | 2020 | 84 | 0.160 |
Why?
|
| Alanine | 4 | 2023 | 163 | 0.160 |
Why?
|
| Colitis | 2 | 2012 | 159 | 0.160 |
Why?
|
| Cerebral Palsy | 5 | 2022 | 87 | 0.160 |
Why?
|
| Odds Ratio | 2 | 2020 | 1236 | 0.160 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 403 | 0.160 |
Why?
|
| Vitamin D | 1 | 2022 | 194 | 0.160 |
Why?
|
| Language Development | 1 | 2020 | 36 | 0.150 |
Why?
|
| Work-Life Balance | 1 | 2019 | 2 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 223 | 0.150 |
Why?
|
| Retinopathy of Prematurity | 2 | 2022 | 64 | 0.150 |
Why?
|
| Birth Intervals | 1 | 2019 | 3 | 0.150 |
Why?
|
| Fetal Diseases | 2 | 2020 | 461 | 0.150 |
Why?
|
| Chenodeoxycholic Acid | 2 | 2025 | 19 | 0.150 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 138 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 111 | 0.150 |
Why?
|
| Infant Equipment | 1 | 2018 | 5 | 0.150 |
Why?
|
| Incubators, Infant | 1 | 2018 | 4 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 229 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 299 | 0.140 |
Why?
|
| Rifampin | 1 | 2019 | 122 | 0.140 |
Why?
|
| Gender Identity | 1 | 2019 | 74 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2863 | 0.140 |
Why?
|
| Morbidity | 4 | 2022 | 261 | 0.140 |
Why?
|
| Administration, Intravenous | 2 | 2025 | 170 | 0.140 |
Why?
|
| Drug Resistance, Fungal | 1 | 2018 | 29 | 0.140 |
Why?
|
| Intensive Care, Neonatal | 2 | 2016 | 56 | 0.140 |
Why?
|
| Cytokines | 3 | 2024 | 1354 | 0.140 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2018 | 20 | 0.140 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 6 | 0.140 |
Why?
|
| Clostridium | 1 | 2018 | 17 | 0.140 |
Why?
|
| Registries | 7 | 2018 | 1598 | 0.140 |
Why?
|
| Carbon Dioxide | 9 | 2013 | 272 | 0.140 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 21 | 0.140 |
Why?
|
| Bacillus | 1 | 2018 | 37 | 0.140 |
Why?
|
| Candidiasis, Invasive | 1 | 2018 | 23 | 0.140 |
Why?
|
| Carrier State | 1 | 1998 | 80 | 0.140 |
Why?
|
| Metabolome | 1 | 2020 | 326 | 0.140 |
Why?
|
| Kupffer Cells | 1 | 2017 | 20 | 0.140 |
Why?
|
| Epithelial Cells | 4 | 2013 | 900 | 0.140 |
Why?
|
| Hepatocytes | 2 | 2017 | 236 | 0.140 |
Why?
|
| Milk Proteins | 1 | 1998 | 86 | 0.130 |
Why?
|
| Endotoxins | 1 | 2017 | 50 | 0.130 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 108 | 0.130 |
Why?
|
| Ferritins | 1 | 2018 | 109 | 0.130 |
Why?
|
| Portal System | 9 | 2007 | 35 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 135 | 0.130 |
Why?
|
| Jejunostomy | 2 | 2014 | 21 | 0.130 |
Why?
|
| Genotype | 3 | 2018 | 2655 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2019 | 1695 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 4 | 2016 | 170 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2017 | 41 | 0.130 |
Why?
|
| Bacteremia | 1 | 2021 | 428 | 0.130 |
Why?
|
| Uterine Rupture | 1 | 2017 | 16 | 0.130 |
Why?
|
| Dystocia | 1 | 2017 | 25 | 0.130 |
Why?
|
| Labor, Induced | 1 | 2017 | 28 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 1005 | 0.130 |
Why?
|
| Pancreas | 5 | 2019 | 218 | 0.130 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 6 | 0.130 |
Why?
|
| Tissue Distribution | 4 | 2021 | 366 | 0.130 |
Why?
|
| Digestion | 2 | 2009 | 42 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 321 | 0.130 |
Why?
|
| Nutritional Support | 2 | 2018 | 67 | 0.130 |
Why?
|
| Chorioamnionitis | 4 | 2018 | 44 | 0.130 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2013 | 78 | 0.120 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 41 | 0.120 |
Why?
|
| Energy Intake | 1 | 2019 | 502 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2014 | 58 | 0.120 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 2 | 2014 | 13 | 0.120 |
Why?
|
| Milk Substitutes | 2 | 2013 | 7 | 0.120 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 11 | 0.120 |
Why?
|
| Rats | 14 | 2017 | 3462 | 0.120 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2016 | 14 | 0.120 |
Why?
|
| Pregnancy, Multiple | 1 | 2016 | 44 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2018 | 298 | 0.120 |
Why?
|
| Epidemiological Monitoring | 1 | 2016 | 69 | 0.120 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2016 | 57 | 0.120 |
Why?
|
| Developing Countries | 1 | 1998 | 306 | 0.120 |
Why?
|
| Zidovudine | 1 | 2015 | 23 | 0.120 |
Why?
|
| Steroids | 1 | 2016 | 172 | 0.120 |
Why?
|
| Awards and Prizes | 1 | 2016 | 63 | 0.120 |
Why?
|
| Treatment Outcome | 10 | 2023 | 13011 | 0.120 |
Why?
|
| Urea | 3 | 2012 | 226 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1612 | 0.110 |
Why?
|
| Head | 1 | 2016 | 115 | 0.110 |
Why?
|
| Pregnancy Outcome | 4 | 2022 | 630 | 0.110 |
Why?
|
| Education, Medical | 1 | 2019 | 287 | 0.110 |
Why?
|
| Ampicillin Resistance | 1 | 2015 | 18 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2017 | 276 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2017 | 350 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2020 | 712 | 0.110 |
Why?
|
| Cell Division | 6 | 2009 | 731 | 0.110 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 37 | 0.110 |
Why?
|
| Perinatal Mortality | 1 | 2015 | 44 | 0.110 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 64 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 2015 | 47 | 0.110 |
Why?
|
| Mucin-2 | 2 | 2012 | 39 | 0.110 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 101 | 0.110 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 895 | 0.110 |
Why?
|
| Inservice Training | 1 | 2015 | 55 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 502 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 998 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 444 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 288 | 0.110 |
Why?
|
| Abdomen | 1 | 2015 | 133 | 0.110 |
Why?
|
| Virulence | 1 | 2015 | 273 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2014 | 31 | 0.110 |
Why?
|
| Cultural Diversity | 1 | 2015 | 78 | 0.110 |
Why?
|
| Fluoroquinolones | 1 | 2015 | 94 | 0.110 |
Why?
|
| Critical Illness | 2 | 2017 | 616 | 0.110 |
Why?
|
| Cognition | 1 | 2020 | 845 | 0.110 |
Why?
|
| Child Abuse | 1 | 2017 | 223 | 0.110 |
Why?
|
| Cultural Competency | 1 | 2015 | 50 | 0.110 |
Why?
|
| Demography | 3 | 2020 | 243 | 0.110 |
Why?
|
| Magnesium Sulfate | 1 | 2014 | 51 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 132 | 0.100 |
Why?
|
| Plasmids | 1 | 2015 | 455 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2001 | 786 | 0.100 |
Why?
|
| Glutamates | 2 | 1991 | 59 | 0.100 |
Why?
|
| Hypotension | 1 | 2015 | 185 | 0.100 |
Why?
|
| Nutritional Requirements | 3 | 2006 | 160 | 0.100 |
Why?
|
| Cerebral Infarction | 1 | 2013 | 46 | 0.100 |
Why?
|
| Narcotics | 1 | 2014 | 59 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2018 | 340 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 153 | 0.100 |
Why?
|
| Patient Selection | 1 | 2017 | 726 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 724 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 5298 | 0.100 |
Why?
|
| Social Conditions | 1 | 2013 | 5 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2015 | 1345 | 0.100 |
Why?
|
| Placenta Diseases | 1 | 2014 | 66 | 0.100 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2010 | 11 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1413 | 0.100 |
Why?
|
| Organizational Innovation | 1 | 2013 | 44 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 81 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 188 | 0.100 |
Why?
|
| Tritium | 4 | 2009 | 112 | 0.100 |
Why?
|
| Infusions, Parenteral | 3 | 2021 | 78 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 427 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2013 | 61 | 0.100 |
Why?
|
| Delphi Technique | 2 | 2025 | 264 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 20 | 0.100 |
Why?
|
| Linear Models | 3 | 2022 | 695 | 0.100 |
Why?
|
| Length of Stay | 1 | 2018 | 1400 | 0.100 |
Why?
|
| Phylogeny | 1 | 2015 | 712 | 0.090 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 96 | 0.090 |
Why?
|
| Thionucleosides | 1 | 2012 | 5 | 0.090 |
Why?
|
| Proline | 1 | 2012 | 80 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 564 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 57 | 0.090 |
Why?
|
| Endpoint Determination | 1 | 2012 | 57 | 0.090 |
Why?
|
| Incretins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 353 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1269 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2016 | 798 | 0.090 |
Why?
|
| Apoptosis | 5 | 2006 | 1860 | 0.090 |
Why?
|
| Survival Rate | 4 | 2021 | 2154 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 687 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2015 | 1522 | 0.090 |
Why?
|
| Cells, Cultured | 7 | 2017 | 2963 | 0.090 |
Why?
|
| Consensus | 2 | 2025 | 530 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 143 | 0.090 |
Why?
|
| Glutathione | 4 | 2011 | 198 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Nitrogen Isotopes | 3 | 2018 | 45 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 124 | 0.090 |
Why?
|
| Growth Substances | 2 | 2002 | 102 | 0.090 |
Why?
|
| Sex Factors | 3 | 2025 | 1352 | 0.090 |
Why?
|
| Malates | 1 | 1991 | 8 | 0.090 |
Why?
|
| Stomach | 3 | 2009 | 274 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 91 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 45 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2014 | 810 | 0.080 |
Why?
|
| Obesity | 2 | 2024 | 2392 | 0.080 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 2 | 2022 | 9 | 0.080 |
Why?
|
| Rodentia | 2 | 2008 | 50 | 0.080 |
Why?
|
| RNA, Messenger | 6 | 2016 | 2573 | 0.080 |
Why?
|
| Fasting | 2 | 2005 | 303 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2025 | 49 | 0.080 |
Why?
|
| Health Policy | 1 | 2013 | 227 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 1991 | 83 | 0.080 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2010 | 33 | 0.080 |
Why?
|
| Dicarboxylic Acids | 1 | 1991 | 37 | 0.080 |
Why?
|
| Animals, Domestic | 2 | 2017 | 37 | 0.080 |
Why?
|
| Candidiasis | 1 | 2011 | 132 | 0.080 |
Why?
|
| Infusions, Intravenous | 4 | 2018 | 551 | 0.080 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 1989 | 10 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2016 | 558 | 0.080 |
Why?
|
| Gene Expression | 5 | 2014 | 1503 | 0.080 |
Why?
|
| Perfusion | 7 | 1994 | 211 | 0.080 |
Why?
|
| Feeding Methods | 2 | 2019 | 36 | 0.080 |
Why?
|
| Pneumonia | 1 | 2013 | 344 | 0.080 |
Why?
|
| Serum Amyloid A Protein | 3 | 2015 | 23 | 0.080 |
Why?
|
| Treponema pallidum | 2 | 2019 | 48 | 0.080 |
Why?
|
| Poverty | 1 | 2013 | 456 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 505 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1840 | 0.080 |
Why?
|
| Time Factors | 7 | 2020 | 6285 | 0.080 |
Why?
|
| Bacterial Translocation | 2 | 2006 | 24 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 491 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2483 | 0.070 |
Why?
|
| Age of Onset | 2 | 2021 | 631 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 643 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 928 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2013 | 1239 | 0.070 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 32 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1991 | 199 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2022 | 792 | 0.070 |
Why?
|
| Spleen | 2 | 2006 | 257 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2020 | 3708 | 0.070 |
Why?
|
| Maternal Age | 2 | 2019 | 136 | 0.070 |
Why?
|
| Galactose | 2 | 2009 | 53 | 0.070 |
Why?
|
| Delivery Rooms | 2 | 2018 | 20 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 866 | 0.070 |
Why?
|
| Pulmonary Surfactants | 2 | 2018 | 45 | 0.070 |
Why?
|
| Oxygen | 1 | 2011 | 553 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2357 | 0.070 |
Why?
|
| Syphilis Serodiagnosis | 2 | 1999 | 15 | 0.070 |
Why?
|
| Deuterium | 2 | 2017 | 95 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2024 | 1638 | 0.060 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 27 | 0.060 |
Why?
|
| Olive Oil | 2 | 2019 | 24 | 0.060 |
Why?
|
| Adenosine Triphosphate | 3 | 2006 | 265 | 0.060 |
Why?
|
| Biological Transport | 4 | 1991 | 333 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2021 | 838 | 0.060 |
Why?
|
| Adolescent | 6 | 2020 | 21008 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2023 | 1224 | 0.060 |
Why?
|
| Age Factors | 4 | 2017 | 2869 | 0.060 |
Why?
|
| Microvilli | 4 | 2013 | 64 | 0.060 |
Why?
|
| Rats, Wistar | 7 | 1996 | 309 | 0.060 |
Why?
|
| Hexoses | 1 | 2005 | 10 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1610 | 0.060 |
Why?
|
| Trypsin | 1 | 2005 | 83 | 0.060 |
Why?
|
| Malabsorption Syndromes | 1 | 2005 | 28 | 0.060 |
Why?
|
| alpha-Glucosidases | 3 | 2013 | 32 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2018 | 976 | 0.060 |
Why?
|
| Carbon Radioisotopes | 2 | 1998 | 68 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3135 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1406 | 0.060 |
Why?
|
| Peroxidase | 3 | 2012 | 64 | 0.060 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2025 | 26 | 0.060 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1997 | 37 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2004 | 710 | 0.060 |
Why?
|
| Models, Biological | 4 | 2009 | 1396 | 0.060 |
Why?
|
| Spontaneous Perforation | 1 | 2024 | 4 | 0.050 |
Why?
|
| Osmolar Concentration | 5 | 2001 | 148 | 0.050 |
Why?
|
| Cattle | 3 | 2013 | 521 | 0.050 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2004 | 6 | 0.050 |
Why?
|
| DNA | 4 | 2005 | 1440 | 0.050 |
Why?
|
| Heart Failure | 1 | 2017 | 2315 | 0.050 |
Why?
|
| Enteroendocrine Cells | 2 | 2019 | 18 | 0.050 |
Why?
|
| Peroxides | 2 | 1994 | 7 | 0.050 |
Why?
|
| Zeaxanthins | 1 | 2023 | 8 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 400 | 0.050 |
Why?
|
| Plant Oils | 2 | 2014 | 34 | 0.050 |
Why?
|
| Lutein | 1 | 2023 | 14 | 0.050 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Symporters | 1 | 2004 | 75 | 0.050 |
Why?
|
| Hepatic Artery | 1 | 2003 | 47 | 0.050 |
Why?
|
| Hormones | 2 | 2002 | 165 | 0.050 |
Why?
|
| Cognition Disorders | 2 | 2018 | 565 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 57 | 0.050 |
Why?
|
| HIV Infections | 1 | 2015 | 2042 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2003 | 64 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2024 | 184 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2003 | 99 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 123 | 0.050 |
Why?
|
| Carotenoids | 1 | 2023 | 80 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 1236 | 0.050 |
Why?
|
| Gonorrhea | 1 | 1982 | 42 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 832 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 955 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2088 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2016 | 1572 | 0.050 |
Why?
|
| Oxygen Consumption | 3 | 2011 | 301 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 31 | 0.050 |
Why?
|
| Dogs | 2 | 2003 | 632 | 0.040 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 48 | 0.040 |
Why?
|
| Growth and Development | 1 | 2021 | 21 | 0.040 |
Why?
|
| Nucleotides | 1 | 2002 | 90 | 0.040 |
Why?
|
| Lactase-Phlorizin Hydrolase | 1 | 2001 | 20 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 43 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 3095 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2004 | 363 | 0.040 |
Why?
|
| Causality | 1 | 2021 | 92 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 1018 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 104 | 0.040 |
Why?
|
| Gastrointestinal Hormones | 1 | 2001 | 20 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2018 | 249 | 0.040 |
Why?
|
| G(M1) Ganglioside | 1 | 1980 | 9 | 0.040 |
Why?
|
| Charcoal | 1 | 1980 | 8 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2020 | 9 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 215 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 1980 | 43 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 293 | 0.040 |
Why?
|
| Blood Culture | 1 | 2021 | 36 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 85 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 2000 | 17 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2002 | 349 | 0.040 |
Why?
|
| Cholera | 1 | 1980 | 38 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 80 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 102 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 63 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2007 | 1093 | 0.040 |
Why?
|
| Gangliosides | 1 | 1980 | 74 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 4762 | 0.040 |
Why?
|
| DNA Primers | 2 | 2013 | 609 | 0.040 |
Why?
|
| Body Composition | 2 | 2019 | 550 | 0.040 |
Why?
|
| Regional Blood Flow | 3 | 2006 | 195 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2013 | 493 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 622 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 324 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2020 | 40 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 51 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 64 | 0.040 |
Why?
|
| Child Health | 1 | 2020 | 66 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 358 | 0.040 |
Why?
|
| Bottle Feeding | 1 | 2019 | 39 | 0.040 |
Why?
|
| Research Design | 1 | 2023 | 723 | 0.040 |
Why?
|
| Algorithms | 3 | 2017 | 1686 | 0.040 |
Why?
|
| Lactates | 1 | 1999 | 82 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2000 | 140 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 567 | 0.040 |
Why?
|
| Maternal Health | 1 | 2019 | 28 | 0.040 |
Why?
|
| Motor Disorders | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 261 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 4961 | 0.040 |
Why?
|
| Sucrase | 2 | 2013 | 23 | 0.040 |
Why?
|
| Ligation | 1 | 2018 | 137 | 0.040 |
Why?
|
| Mathematics | 1 | 1998 | 72 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 1996 | 9 | 0.040 |
Why?
|
| Fluconazole | 1 | 2018 | 48 | 0.040 |
Why?
|
| Dipeptides | 1 | 2018 | 64 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 90 | 0.040 |
Why?
|
| Albumins | 1 | 1998 | 92 | 0.040 |
Why?
|
| Glycine | 3 | 1997 | 166 | 0.030 |
Why?
|
| Intellectual Disability | 2 | 2016 | 1082 | 0.030 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2017 | 17 | 0.030 |
Why?
|
| Atrophy | 2 | 2011 | 251 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1998 | 166 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 187 | 0.030 |
Why?
|
| Methylation | 2 | 2009 | 201 | 0.030 |
Why?
|
| Arteries | 1 | 1999 | 210 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 225 | 0.030 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2017 | 16 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2019 | 234 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2018 | 148 | 0.030 |
Why?
|
| Pandemics | 1 | 2025 | 1165 | 0.030 |
Why?
|
| Cause of Death | 1 | 2019 | 512 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 2017 | 20 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2018 | 178 | 0.030 |
Why?
|
| Micelles | 1 | 2017 | 19 | 0.030 |
Why?
|
| Granulocytes | 1 | 2017 | 69 | 0.030 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 58 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 144 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 56 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 70 | 0.030 |
Why?
|
| Carbon | 1 | 1997 | 94 | 0.030 |
Why?
|
| Weaning | 2 | 2011 | 52 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 86 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 389 | 0.030 |
Why?
|
| Observation | 1 | 2016 | 39 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2017 | 164 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2017 | 108 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2016 | 28 | 0.030 |
Why?
|
| Raffinose | 2 | 1994 | 7 | 0.030 |
Why?
|
| Asia, Western | 1 | 2016 | 5 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.030 |
Why?
|
| Back Muscles | 1 | 2016 | 4 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 147 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 443 | 0.030 |
Why?
|
| Health Surveys | 1 | 2017 | 263 | 0.030 |
Why?
|
| Amino Acid Transport System A | 1 | 2016 | 7 | 0.030 |
Why?
|
| Deafness | 1 | 2016 | 83 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 193 | 0.030 |
Why?
|
| Mice | 4 | 2017 | 18504 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 519 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 82 | 0.030 |
Why?
|
| Blindness | 1 | 2016 | 72 | 0.030 |
Why?
|
| Perinatal Care | 1 | 2016 | 68 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2016 | 30 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 37 | 0.030 |
Why?
|
| Sympathomimetics | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2011 | 333 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 191 | 0.030 |
Why?
|
| Cameroon | 1 | 2015 | 10 | 0.030 |
Why?
|
| Nevirapine | 1 | 2015 | 14 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 37 | 0.030 |
Why?
|
| Checklist | 1 | 2016 | 101 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2016 | 71 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 244 | 0.030 |
Why?
|
| Lamivudine | 1 | 2015 | 29 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 388 | 0.030 |
Why?
|
| Cell Size | 2 | 1992 | 79 | 0.030 |
Why?
|
| Dobutamine | 1 | 2015 | 55 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2006 | 60 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1996 | 81 | 0.030 |
Why?
|
| Patient Participation | 1 | 2018 | 245 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 427 | 0.030 |
Why?
|
| Ion Channels | 1 | 2017 | 206 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2015 | 15 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 272 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 28 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 173 | 0.030 |
Why?
|
| Caspases | 2 | 2006 | 157 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 277 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 194 | 0.030 |
Why?
|
| Health Behavior | 1 | 2018 | 390 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 150 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 240 | 0.030 |
Why?
|
| Neurosyphilis | 1 | 1994 | 15 | 0.030 |
Why?
|
| Informed Consent | 1 | 2017 | 343 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 372 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 773 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 256 | 0.030 |
Why?
|
| Single Umbilical Artery | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 260 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 741 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1146 | 0.030 |
Why?
|
| Chorionic Villi | 1 | 2014 | 22 | 0.030 |
Why?
|
| Sorbitol | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1994 | 117 | 0.030 |
Why?
|
| Cotinine | 1 | 2014 | 26 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 40 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4531 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 322 | 0.030 |
Why?
|
| Term Birth | 1 | 2013 | 35 | 0.030 |
Why?
|
| Cell Count | 2 | 2004 | 217 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 313 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 428 | 0.030 |
Why?
|
| Cross Infection | 1 | 2017 | 339 | 0.030 |
Why?
|
| Animals, Inbred Strains | 1 | 2013 | 5 | 0.030 |
Why?
|
| Latin America | 1 | 2013 | 102 | 0.030 |
Why?
|
| Asia | 1 | 2013 | 125 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2013 | 121 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1519 | 0.030 |
Why?
|
| Enzyme Precursors | 2 | 2004 | 22 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 168 | 0.020 |
Why?
|
| Cannabis | 1 | 2014 | 49 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1457 | 0.020 |
Why?
|
| Data Collection | 1 | 2015 | 372 | 0.020 |
Why?
|
| Caprylates | 1 | 2013 | 19 | 0.020 |
Why?
|
| Cell Survival | 2 | 2006 | 854 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 235 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 140 | 0.020 |
Why?
|
| Bucladesine | 1 | 1992 | 18 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 482 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 280 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2014 | 179 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 635 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1992 | 37 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 138 | 0.020 |
Why?
|
| Pentose Phosphate Pathway | 1 | 1992 | 44 | 0.020 |
Why?
|
| Immunoassay | 1 | 1993 | 133 | 0.020 |
Why?
|
| Vasopressins | 1 | 1992 | 44 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 69 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 188 | 0.020 |
Why?
|
| Keto Acids | 1 | 1992 | 50 | 0.020 |
Why?
|
| Ketones | 1 | 1992 | 27 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 207 | 0.020 |
Why?
|
| Bifidobacterium | 1 | 2012 | 66 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 161 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Anesthesia | 1 | 2014 | 209 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 2697 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 12 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 226 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 356 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Global Health | 1 | 2016 | 633 | 0.020 |
Why?
|
| Mesentery | 1 | 2011 | 28 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 300 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 242 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 65 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2001 | 135 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1153 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 359 | 0.020 |
Why?
|
| Hepatic Veins | 1 | 1991 | 20 | 0.020 |
Why?
|
| Peptide YY | 2 | 2001 | 20 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 57 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 216 | 0.020 |
Why?
|
| Actins | 1 | 1992 | 317 | 0.020 |
Why?
|
| Catheterization | 2 | 2002 | 234 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 28911 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 567 | 0.020 |
Why?
|
| Isotopes | 1 | 2009 | 25 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 90 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 185 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2009 | 15 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 692 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 141 | 0.020 |
Why?
|
| Curriculum | 1 | 2015 | 785 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 70 | 0.020 |
Why?
|
| Uracil Nucleotides | 1 | 1988 | 9 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 1988 | 9 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 1988 | 17 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 74 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 143 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1078 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 104 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 355 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 328 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 493 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2123 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 51 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 37 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 56 | 0.020 |
Why?
|
| fas Receptor | 1 | 2006 | 43 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 67 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 87 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 79 | 0.020 |
Why?
|
| Enterotoxins | 1 | 2006 | 77 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 88 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 140 | 0.020 |
Why?
|
| Ribotyping | 1 | 2006 | 49 | 0.020 |
Why?
|
| Blood | 1 | 2006 | 100 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 106 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2006 | 17 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 156 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 432 | 0.010 |
Why?
|
| Bilirubin | 1 | 2006 | 127 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2006 | 133 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2005 | 6 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 50 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 209 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 171 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1902 | 0.010 |
Why?
|
| Caspase 6 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2004 | 32 | 0.010 |
Why?
|
| Texas | 1 | 2013 | 3629 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 127 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 1994 | 91 | 0.010 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2004 | 34 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 754 | 0.010 |
Why?
|
| Infant Food | 1 | 2004 | 73 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 2 | 1994 | 7 | 0.010 |
Why?
|
| Claudin-1 | 1 | 2003 | 19 | 0.010 |
Why?
|
| Enterocytes | 1 | 2004 | 68 | 0.010 |
Why?
|
| Diuresis | 1 | 2003 | 45 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 2003 | 5 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 2003 | 52 | 0.010 |
Why?
|
| Liver Circulation | 1 | 2003 | 19 | 0.010 |
Why?
|
| Tight Junctions | 1 | 2003 | 39 | 0.010 |
Why?
|
| Permeability | 1 | 2003 | 120 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 59 | 0.010 |
Why?
|
| Enteritis | 1 | 2003 | 52 | 0.010 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2003 | 47 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 50 | 0.010 |
Why?
|
| Hypotonic Solutions | 2 | 1992 | 12 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3928 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 286 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 361 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2002 | 74 | 0.010 |
Why?
|
| Parity | 1 | 1982 | 84 | 0.010 |
Why?
|
| Glucagon | 2 | 1992 | 146 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 148 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2002 | 126 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1996 | 824 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 1982 | 96 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 464 | 0.010 |
Why?
|
| CD13 Antigens | 1 | 2001 | 10 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1994 | 230 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 2001 | 8 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2001 | 20 | 0.010 |
Why?
|
| Georgia | 1 | 2001 | 46 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 84 | 0.010 |
Why?
|
| Intestine, Large | 1 | 2000 | 12 | 0.010 |
Why?
|
| Adsorption | 1 | 1980 | 34 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 602 | 0.010 |
Why?
|
| Urban Health | 1 | 2001 | 85 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 95 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 65 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 122 | 0.010 |
Why?
|
| Dehydration | 1 | 1980 | 41 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2001 | 99 | 0.010 |
Why?
|
| Gastrins | 1 | 2000 | 30 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 2001 | 69 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 188 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2000 | 42 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2566 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2001 | 397 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3616 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 359 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 614 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1997 | 43 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1997 | 52 | 0.010 |
Why?
|
| Cell Movement | 1 | 2001 | 886 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 427 | 0.010 |
Why?
|
| Feces | 1 | 1980 | 725 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 93 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 258 | 0.010 |
Why?
|
| Tyrosine Transaminase | 1 | 1996 | 6 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 1998 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 236 | 0.010 |
Why?
|
| Anisotropy | 1 | 1996 | 124 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1980 | 1141 | 0.010 |
Why?
|
| Maleimides | 1 | 1994 | 10 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1994 | 21 | 0.010 |
Why?
|
| Lumicolchicines | 1 | 1994 | 1 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1994 | 9 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1994 | 10 | 0.010 |
Why?
|
| Barium Compounds | 1 | 1994 | 6 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1994 | 31 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1994 | 28 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 825 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1994 | 65 | 0.010 |
Why?
|
| Dextrans | 1 | 1994 | 45 | 0.010 |
Why?
|
| Colchicine | 1 | 1994 | 40 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1994 | 79 | 0.010 |
Why?
|
| Histidine | 1 | 1994 | 74 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 99 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1994 | 114 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2148 | 0.010 |
Why?
|
| Endocytosis | 1 | 1994 | 129 | 0.010 |
Why?
|
| Indoles | 1 | 1994 | 205 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 252 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 989 | 0.010 |
Why?
|
| Dinitrochlorobenzene | 1 | 1992 | 2 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1992 | 21 | 0.010 |
Why?
|
| Osmosis | 1 | 1992 | 17 | 0.010 |
Why?
|
| Bile | 1 | 1992 | 44 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1992 | 37 | 0.010 |
Why?
|
| NAD | 1 | 1992 | 50 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1994 | 520 | 0.010 |
Why?
|
| Phosphorylases | 1 | 1988 | 7 | 0.000 |
Why?
|
| Acetophenones | 1 | 1988 | 11 | 0.000 |
Why?
|
| Dinoprost | 1 | 1988 | 25 | 0.000 |
Why?
|
| Tetrazoles | 1 | 1988 | 72 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1988 | 590 | 0.000 |
Why?
|